Attached files
| file | filename |
|---|---|
| EX-99.1 - EX-99.1 - AUXILIUM PHARMACEUTICALS INC | a14-20707_2ex99d1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): September 10, 2014
Auxilium Pharmaceuticals, Inc.
(Exact Name of Registrant Specified in Charter)
|
Delaware (State or Other Jurisdiction of Incorporation) |
|
000-50855 (Commission File Number) |
|
23-3016883 (I.R.S. Employer Identification No.) |
|
640 Lee Road |
|
|
|
Chesterbrook, PA |
|
19087 |
|
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code: (484) 321-5900
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 Regulation FD Disclosure.
As previously announced, certain members of the executive management team will participate in the Morgan Stanley Healthcare Conference to be held September 8-10, 2014 in New York. Adrian Adams, Chief Executive Officer and President, is scheduled to present an overview of the Company and its product portfolio at 10:55 a.m. ET on Wednesday, September 10, 2014.
The presentation will also be webcast on the “Investors” section of the Auxilium website under the “Events” tab on September 10, 2014. To access the live webcast, please log on to Auxilium’s site approximately 15 minutes prior to the presentation to register and download any necessary audio software. The presentation replay will be available for 90 days after the event.
A copy of the presentation materials is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
The following presentation is furnished as an exhibit to this Current Report on Form 8-K pursuant to Item 7.01 and shall not be deemed to be “filed”:
99.1 Presentation materials to be first used by Adrian Adams, the Company’s Chief Executive Officer and President, on September 10, 2014.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
AUXILIUM PHARMACEUTICALS, INC. | ||
|
|
| ||
|
|
|
| |
|
Date: September 10, 2014 |
|
By: |
/s/ Andrew I. Koven |
|
|
|
|
Andrew I. Koven |
|
|
|
|
Chief Administrative Officer and General Counsel |